Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Novartis AG share price up, new heart-failure treatment to receive an accelerated review by European authorities

November 29, 2014 11:17 am
Novartis AG announced that an accelerated review by the European authorities has been granted to a new drug for treating heart failure, improving its chances for getting a regulatory approval in Europe within 2015. The Committee for Medicinal Products for Human Use, part of the European Medicines Agency which reviews drugs and makes recommendations related […] Read more